中国药业
中國藥業
중국약업
China Pharmaceuticals
2015年
18期
49-50
,共2页
徐凤华%董月华%薛净%李明
徐鳳華%董月華%薛淨%李明
서봉화%동월화%설정%리명
二乙酰氨乙酸乙二胺%肝硬化%消化道出血%复发
二乙酰氨乙痠乙二胺%肝硬化%消化道齣血%複髮
이을선안을산을이알%간경화%소화도출혈%복발
ethylenediamine diaceturate%liver cirrhosis%gastrointestinal hemorrhage%recurrence
目的:探讨二乙酰氨乙酸乙二胺治疗肝硬化消化道出血的临床疗效。方法将104例患者随机分为对照组和观察组,各52例。对照组患者在卧床休息、禁食、静脉补充电解质和水、抗感染等内科常规治疗基础上使用奥曲肽止血,观察组患者则将止血药物换为二乙酰氨乙酸乙二胺,其余治疗方案相同。结果治疗后,观察组总有效率为73.08%,明显高于对照组的59.61%( P﹤0.05);两组患者治疗后的血红蛋白及脉率较治疗前显著降低( P﹤0.05),但组间比较无明显差异( P﹥0.05);两组已止血患者1周后复发率,观察组为5.26%,显著低于对照组的12.90%( P﹤0.05);治疗前后凝血功能及血小板功能变化情况,观察组有显著好转( P﹤0.05),对照组未见明显变化( P﹥0.05);两组患者药品不良反应发生率间未见显著性差异。结论二乙酰氨乙酸乙二胺治疗肝硬化合并消化道出血疗效确切,安全性高,能显著降低患者已止血后的复发率。
目的:探討二乙酰氨乙痠乙二胺治療肝硬化消化道齣血的臨床療效。方法將104例患者隨機分為對照組和觀察組,各52例。對照組患者在臥床休息、禁食、靜脈補充電解質和水、抗感染等內科常規治療基礎上使用奧麯肽止血,觀察組患者則將止血藥物換為二乙酰氨乙痠乙二胺,其餘治療方案相同。結果治療後,觀察組總有效率為73.08%,明顯高于對照組的59.61%( P﹤0.05);兩組患者治療後的血紅蛋白及脈率較治療前顯著降低( P﹤0.05),但組間比較無明顯差異( P﹥0.05);兩組已止血患者1週後複髮率,觀察組為5.26%,顯著低于對照組的12.90%( P﹤0.05);治療前後凝血功能及血小闆功能變化情況,觀察組有顯著好轉( P﹤0.05),對照組未見明顯變化( P﹥0.05);兩組患者藥品不良反應髮生率間未見顯著性差異。結論二乙酰氨乙痠乙二胺治療肝硬化閤併消化道齣血療效確切,安全性高,能顯著降低患者已止血後的複髮率。
목적:탐토이을선안을산을이알치료간경화소화도출혈적림상료효。방법장104례환자수궤분위대조조화관찰조,각52례。대조조환자재와상휴식、금식、정맥보충전해질화수、항감염등내과상규치료기출상사용오곡태지혈,관찰조환자칙장지혈약물환위이을선안을산을이알,기여치료방안상동。결과치료후,관찰조총유효솔위73.08%,명현고우대조조적59.61%( P﹤0.05);량조환자치료후적혈홍단백급맥솔교치료전현저강저( P﹤0.05),단조간비교무명현차이( P﹥0.05);량조이지혈환자1주후복발솔,관찰조위5.26%,현저저우대조조적12.90%( P﹤0.05);치료전후응혈공능급혈소판공능변화정황,관찰조유현저호전( P﹤0.05),대조조미견명현변화( P﹥0.05);량조환자약품불량반응발생솔간미견현저성차이。결론이을선안을산을이알치료간경화합병소화도출혈료효학절,안전성고,능현저강저환자이지혈후적복발솔。
Objective To investigate the efficacy of ethylenediamine diaceturate in treating liver cirrhosis with gastrointestinal hemor-rhage. Methods Totally 104 patients were randomly divided into the control group and the observation group,52 cases in each group. The control groups used octreotide hemostasis treatment on the basis of routine internal medicine treatment,the observation group were given ethylenediamine diaceturate to replace the hemostatic drug,and the other treatment remained unchanged. Results After treatment,the total effective rate of the observation group was 73. 08%,which was obviously higher than 59. 61% of the control group ( P ﹤ 0. 05 );the hemoglobin and pulse rate of the two groups were significantly decreased( P ﹤ 0. 05),but there was no significant difference between the two( P ﹥ 0. 05);the recurrence bleeding rate of the observation group was 5. 26%,which was significantly lower than 12. 90% of the control group( P ﹤ 0. 05);the coagulation function and platelet function in the observation group improved signifi-cantly( P ﹤ 0. 05),and the control group showed no significant change( P ﹥ 0. 05). The adverse reactions of the two groups had no significant difference. Conclusion Ethylenediamine diaceturate in treating liver cirrhosis with upper gastrointestinal hemorrhage has exact effect,and good safety and can significantly reduce the recurrence rate after patients stopped bleeding.